Drug formulation technologists are specialized experts who focus on the development and refinement of pharmaceutical products to ensure that drugs deliver their intended therapeutic effects safely and efficiently. Their responsibilities include designing formulations that balance drug stability, solubility, and bioavailability while maintaining patient compliance. They work with a range of dosage forms such as tablets, capsules, injectables, and topical applications, selecting appropriate excipients and optimizing processing parameters. By using advanced techniques and scientific knowledge, these technologists ensure that the final drug product meets rigorous quality standards and regulatory requirements.
Besides formulation development, drug formulation technologists are involved in scaling up processes from the laboratory to commercial manufacturing, ensuring reproducibility and cost-effectiveness. They conduct thorough evaluations, including stability testing, dissolution profiling, and compatibility assessments, to guarantee product performance throughout its shelf life. Collaboration with cross-functional teams—such as regulatory affairs, quality control, and production—is essential to address challenges and accelerate time-to-market. As the pharmaceutical landscape evolves with emerging technologies like controlled-release systems and nanocarriers, drug formulation technologists continue to play a pivotal role in advancing drug delivery science and improving patient outcomes worldwide. Their expertise is crucial in driving innovation and ensuring that new medicines reach patients safely and efficiently. Ultimately, their work helps transform scientific discoveries into practical treatments that improve global health.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada